1. Home
  2. ALLR vs BANL Comparison

ALLR vs BANL Comparison

Compare ALLR & BANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

N/A

Current Price

$0.87

Market Cap

19.3M

Sector

Health Care

ML Signal

N/A

BANL

CBL International Limited

N/A

Current Price

$3.39

Market Cap

19.0M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
ALLR
BANL
Founded
2004
2015
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil Refining/Marketing
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
19.0M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ALLR
BANL
Price
$0.87
$3.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 114.8K
16.9K
Earning Date
11-13-2026
08-18-2026
Dividend Yield
N/A
★ 2.50%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $320,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.27
52 Week High
$1.84
$16.40

Technical Indicators

Market Signals
Indicator
ALLR
BANL
Relative Strength Index (RSI) 39.12 41.15
Support Level $0.79 $0.37
Resistance Level $1.45 $5.18
Average True Range (ATR) 0.07 0.48
MACD 0.01 0.20
Stochastic Oscillator 43.87 34.16

Price Performance

Historical Comparison
ALLR
BANL

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About BANL CBL International Limited

CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.

Share on Social Networks: